Medicine News
| 5/13/2008 | First Recombinant Room Temperature Stable Treatment for Hemophilia With Inhibitors Offers More Flexibility and Convenience to Patients PRINCETON, N.J., May 13 /- Novo Nordisk todayannounced that the US Food and Drug Administration (FDA) has approvedNovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room TemperatureStable), the first room temperature stable r... [Comments] |
Hospital pay for performance incentives may backfire among safety-net hospitals
| 5/13/2008 | (PHILADELPHIA) The same government-backed incentive programs aimed at improving the care all Americans receive in hospitals may be widening the gap between poor, underserved patients and those who are insured or can afford to pay for their own care, according to a new study led by a University of Pennsylvania School of Medicine physician. Though public reporting and pay for performance ar... [Comments] |
Amil Has Strong Growth With High Profitability
| 5/13/2008 | 29% Revenue Increase and 45% Profit Growth RIO DE JANEIRO, Brazil, May 13 /- Amilpar(BOVESPA: AMIL3, Bloomberg: AMIL3 BZ e Reuters: AMIL3.SA), the largestmanaged care organization in Brazil, announced today its consolidatedresults for the first quarter 2008. 1st QUARTER 2008 Highlights -- Total membership stood at 2.84 mil... [Comments] |
Charities Form Alliance to Preserve and Improve Charity Bingo
| 5/13/2008 | Nonprofit groups depend on electronic bingo to fulfill the unmet needs of individuals, families, children and communities SACRAMENTO, Calif., May 13 /- The California CharityAlliance (CCA) today announced its formation to advocate for the use oftraditional and technologically advanced forms of bingo as a responsible,legal and consistent funding source for nonprofit... [Comments] |
Z Trim Holdings, Inc. Audit Report Contains 'Going Concern' Qualification
| 5/13/2008 | MUNDELEIN, Ill., May 13 /- Z Trim Holdings, Inc.(Amex: ZTM ) announced today that its recently filed financial statementsfor the fiscal year ended December 31, 2007 contained a going concernqualification received from its independent registered public accountingfirm, Blackman Kallick LLP. This announcement is being made to comply withSection 610 of the Amex compa... [Comments] |
Veria Announces Acquisition of Massage Envy Ltd.
| 5/13/2008 | Industry Leaders Unite to Provide Comprehensive Wellness Products and Services ARLINGTON, Texas, May 13 /- Veria -- a growing naturalhealth and wellness company combining Veria TV (a 24x7 HD televisionnetwork), local wellness centers, and a lifestyle-focused website -- todayannounced its acquisition of Scottsdale, Ariz.-based Massage Envy Ltd.,... [Comments] |
| 5/13/2008 | Data Recognition Corporation Among 52 Companies Recognized for Promoting Healthy Workplace MAPLE GROVE, Minn., May 13 /- The National Business Groupon Health, a national non-profit organization of large employers, todayhonored Data Recognition Corporation (DRC) for its commitment anddedication to promoting a healthy workplace and encouraging a health... [Comments] |
PA Governor Rendell Signs 3 Bills Into Law
| 5/13/2008 | HARRISBURG, Pa., May 13 -- Governor Edward G.Rendell today signed three bills into law: Senate Bill 636 establishes a voluntary cancer drug repository programthat allows pharmacies, under the supervision of the State Board ofPharmacy, to redispense unused cancer drugs to cancer patients. Under the program, drugs may be returned to an approved pharmacy to be... [Comments] |
New Study: Texas Seniors 4th Hardest-Hit from Proposed Bush Administration Medicare Cuts
| 5/13/2008 | $47 Million Cut in Year-Ahead Nursing Home Funding Harms Patients,Threatens Key Nursing Staff Jobs AUSTIN, Texas, May 13 -- Commenting on anewly-released analysis of the Bush Administration's proposed regulatorychanges that will cut Medicare-financed nursing home care in Texas by $47million in the year ahead -- the 4th highest level of cuts in the nation --th... [Comments] |
| 5/13/2008 | - Both capital sales and rental revenue increase 12.0 percent demonstrating balanced growth- Hill-Rom reporting for first time since separation; strategic investments showing results - Management updates financial guidance based on year to date performance and operational momentum BATESVILLE, Ind., May 13 /PRNewswir... [Comments] |
(Date:5/13/2008)...ISBURG, Pa., May 13 /PRNewswire-USNewswire/ -- Gov...nto law:, Senate Bill 636 establishes a volunta...macies, under the supervision of the State Board o...ancer patients., Under the program, drugs may b...ed, provided that they are in their original packa...
(Date:5/13/2008)...apital sales and rental revenue increase 12.0 perc...ced growth,- Hill-Rom reporting for first time sin... showing results, - Management update...ance and operational moment...l/ -- Hill-Rom Holdings,Inc. (NYSE: HRC ), repor...
(Date:5/13/2008)...FORD, N.J., May 13 /PRNewswire-FirstCall/ -- TOFUT...esults for the thirteen week period ended,March 29...arch 29, 2008 decreased 4% to,$4.65 million compar...n,weeks ended March 31, 2007 due to the discontinu...2008 period that were available for sale in the 20...
(Date:5/13/2008)... LAUDERDALE, Fla., May 13 /PRNewswire-FirstCall/ -...e power of the Internet to bring diet,fitness and...nounced,results for the quarter ended March 31, 20...$8.8 million, compared to,$8.4 million in the prio...as $(5.1) million, or $(0.20) per diluted share, f...
Breaking Medicine News(10 mins):Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 2Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 3Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 4Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 5Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 6Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 7Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 8Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 9Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 10Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 11Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 12Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 13Health News:Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year 14Health News:TOFUTTI Announces First Quarter Results 2Health News:TOFUTTI Announces First Quarter Results 3Health News:TOFUTTI Announces First Quarter Results 4Health News:eDiets.com(R) Announces Q1 2008 Results 2Health News:eDiets.com(R) Announces Q1 2008 Results 3Health News:eDiets.com(R) Announces Q1 2008 Results 4Health News:eDiets.com(R) Announces Q1 2008 Results 5Health News:eDiets.com(R) Announces Q1 2008 Results 6[0] PA Governor Rendell Signs 3 Bills Into Law[0] Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year[0] TOFUTTI Announces First Quarter Results[0] eDiets.com(R) Announces Q1 2008 Results
...t regular vaccination of infants against H. influe...Hib pneumonia and meningitis, could save innumerab...which is published online in The Pediatric Infecti... that routine immunization of infants with a Hib c...
... Alcohol Abuse and Alcoholism (NIAAA), a part of t...dentified five distinct subtypes of alcoholism by...ing from alcohol dependence. Our findings should ...e typical alcoholic, notes first author Dr. Howard...
...e Tyler has revealed that the secret of his relati...uty regime that he follows. The slender rock st...heyday in the 1970s, says that he applies a specia...in order to keep his looks attractive. "I have a...
...plays the role of a woman in movie 'Hairspray', is... weight. The star admits that having to wear a ...character Edna Turnblad in the 2007 remake of the ...ovie was the perfect combination to shed the pound...
Other Medicine News:Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 2Health News:Routine Hib Vaccination Could Save Innumerable Asian Children 3Health News:Researchers Identify Five Distinct Subtypes of Alcoholism 2Health News:Researchers Identify Five Distinct Subtypes of Alcoholism 3...he Finnpipette Digital offers improved ergonomics ...ded handle, modified grippy finger rest and the la...fficiency. Finnpipette Digitals also feature soft-...anism (pat. pend.) and super blow-out for 0.2 - 50...
Research Series 2100 Adjustable-volume Pipette, 20-200 l, single-channel with adjustable-volume setting
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,409-7) or contact custom
Recommended for aqueous samples of moderate viscosity and density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No cleaning, no greasing. Volume Range (ul)
Medicine Products:(Date:5/12/2008)...- Arbios Systems, Inc.,(OTC...mpany has received,approval from the U.S. Food and... Device Exemption ("IDE") to begin the pivotal cli...(outside the body) liver assist,device for blood p...,chronic liver disease., "We are pleased to have ...
(Date:5/12/2008)...ire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY ), a,... company, today announced,the first implantation o...lve in a patient at the Cleveland Clinic. The surg...geon with the Heart and Vascular Institute at,the ... combination aortic-mitral human heart,valve was d...
(Date:5/12/2008)...Demonstrated Improvement in T-Cell Responses ... HspE7, SAN DIEGO, May 12 /PRNewswire-FirstCall/ ...) today announced positive immunological data from...trial of its lead product,candidate, HspE7, in pat...CIN, a precursor to cervical cancer. HPV 16 E7-spe...
(Date:5/9/2008)... /PRNewswire-USNewswire/ -- An emergency,veterinar...f Animals (WSPA),is on stand-by in Thailand awaiti...sess and then relieve the suffering of thousands o...and their livelihoods., WSPA is receiving daily...n of the United Nations (FAO) while preparing its ...
Breaking Medicine Technology:Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic 2CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic 3Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 6Animals That Cyclone Survivors Depend on Need Help Now 2INCF and Allen Institute for Brain Science collaborate on Brain Atlas service improvement 14608 1INCF and Allen Institute for Brain Science collaborate on Brain Atlas service improvement 14608 2INCF and Allen Institute for Brain Science collaborate on Brain Atlas service improvement 14608 3Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 14606 1Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 14606 2Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 14606 3Scientists successfully awaken sleeping stem cells 14604 1Scientists successfully awaken sleeping stem cells 14604 2Families Play a Role in the Development of Eating Disorders 14602 1Families Play a Role in the Development of Eating Disorders 14602 2[0] Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device[0] CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic[0] Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial[0] Animals That Cyclone Survivors Depend on Need Help Now
...USINESS WIRE)--Jun 28, 2007 - CombinatoRx,Incorpo...esults of,its randomized, blinded, placebo-control...umatoid arthritis (RA). The trial,compared CRx-150...RD) to placebo plus DMARD (control) in subjects wi...trial, CRx-150 demonstrated,statistically signific...
...ients treated with VELCADE, cyclophosphamide,and ...28, 2007 /PRNewswire-FirstCall/ -- Millennium,Phar...on of results,from clinical trials of VELCADE base...complete response(1) (CR) rates in previously,trea... were,presented at the prestigious 11th Internatio...
Other Medicine Technology:CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 2CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 3CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 4CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 5Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |